Study finds no benefit to intensive treatment for early type 2 diabetes

08/24/2011 | Medscape (free registration)

Data on more than 1,500 Danish participants with type 2 diabetes found that those in an intensive treatment group had a 7.3% prevalence of ankle-brachial index of 0.9 or less and 30.1% of participants had abnormal neuropathy results six years after screening, compared with 9.1% and 34.8% respectively in the routine care group. The researchers, writing in Diabetes Care, concluded there was no statistically significant effect of intensive management upon early detection of type 2 diabetes.

View Full Article in:

Medscape (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Compliance and Ethics Director
Sysmex America, Inc.
Lincolnshire, IL
Director, Site Quality Management
Palm Springs, CA
Compliance Officer-Medical Products
W. L. Gore
Flagstaff, AZ
Project Manager RA - 15000003MD
Santa Clara, CA
Director, Site Quality Management
Minneapolis, MN